Paasa Logo
MaaT Pharma S.A. logo
MAATPARMarket closedOpens 9:00am CET

MaaT Pharma S.A.

€1.13Last updated
-€0.13 (10.14%)Past day
Timezone

MaaT Pharma S.A. (PAR: MAAT) is trading at €1.13, about ₹124 at today's EUR/INR rate, as of 25 Sep 2026, 11:35 AM ET, down 10.14% today. Indian residents can buy MaaT Pharma from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:€1.30
Previous close:€1.26
Volume:135.55K

Today's low

€1.13

Today's high

€1.30

52 week low

€1.00

52 week high

€8.62

MAAT opened at €1.30, closed previously at €1.26, and has traded between €1.00 and €8.62 over the past 52 weeks.

About

MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.

Country
FR
CEO
Herve Affagard
Exchange listed on
PAR
Industry
Biotechnology
Base currency
EUR
Full Time Employees
56
Sector
Healthcare
IPO date
08/11/2021

Key statistics

Avg. volume

79.64K

Market cap

€21.34M

P/E Ratio

-0.58

Price-to-sales ratio

4.72

Enterprise value

€13.91M

Free cash flow yield

-77.42%

Debt-to-equity ratio

9.69

Return on equity

-615.43%

ROIC

-100.44%

Beta

0.41

Dividend yield

0.00%

Last dividend

€0.00

Financial overview

Revenue

€4.52M

Earnings per share

-€1.95

Free cash flow

-€16.52M

Net profit margin

-686.58%

Gross margin

49.89%

EBITDA

-€32.41M

Revenue growth

40.67%

Similar securities

This is not an investment recommendation

How to buy MaaT Pharma from India

Indian residents can buy MaaT Pharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.

  3. Search for MaaT Pharma and place an order

    Find MaaT Pharma by name or by its ticker, MAAT, and choose an order type. MaaT Pharma trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your MaaT Pharma position in EUR and INR. MaaT Pharma pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in MaaT Pharma from India

Trading and taxes when buying MaaT Pharma from India

Trading and limits

Trading hours
9:00 am – 5:30 pm CET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneMaaT Pharma does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy MaaT Pharma stock?

Yes. MaaT Pharma (MAAT) has been listed on Euronext Paris since 2021, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one MaaT Pharma share cost in rupees?

One MaaT Pharma share is €1.13 — about ₹124 at an EUR/INR rate of 109.20 on 26 Sep 2026. Both the MaaT Pharma price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying MaaT Pharma from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on MaaT Pharma shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the MaaT Pharma price. Paasa issues a capital-gains statement for your return.

Does MaaT Pharma pay a dividend?

No. MaaT Pharma does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade MaaT Pharma from India?

Euronext Paris trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when France is on standard time. Orders can only execute during that window.

Do I have to declare MaaT Pharma shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your MaaT Pharma holding, its cost and its closing value.

How do I sell MaaT Pharma and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.

Does the rupee rate affect what I make on MaaT Pharma?

Yes. MaaT Pharma is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.